switching from liraglutide to tirzepatide Comparing Semaglutide, Liraglutide, and Tirzepatide: Key Insights What is the equivalent dose
Description
[DOI] [PubMed] [Google Scholar] 139.Liu Y.L., Malik N.M., Sanger G.J., Andrews P.L.R
Read the letter here
PMID: 39677183
Diabetes Care , 44 (2), 324331
We utilize Tirzepatide, a next-generation GLP-1/GIP receptor agonist, which has demonstrated substantial benefits in clinical trials for both weight loss and glycemic control
More than 33 million Americans have type 2 diabetes, and Sanyal says between 5% and 7% of these individuals develop clinically significant liver disease
